Industry NewsCellectricon and StressMarq Biosciences to develop assays and reagents for neurodegenerative disease research
Industry NewsAvacta’s proprietary TMAC cancer therapy platform demonstrates successful proof-of-concept in pre-clinical study
Industry NewsAbbott to initiate trial to study MitraClip as an option for moderate surgical risk patients